← Return to Our journey on ALTA3263 clinical trial (tumors with KRAS mutations)

Discussion
howleegirl avatar

Our journey on ALTA3263 clinical trial (tumors with KRAS mutations)

Pancreatic Cancer | Last Active: 1 day ago | Replies (23)
Comment receiving replies
Profile picture for petrouva @petrouva

@tomrennie CT is the same, which is good. Overall, tumor shrunk around 50% from start of treatment in January! Dr appointment tomorrow and will discuss symptoms.

Jump to this post

Replies to "@tomrennie CT is the same, which is good. Overall, tumor shrunk around 50% from start of..."
Turkey, Volunteer Mentor | @tomrennie | 1 day ago

@petrouva That's great. Stability is good. Please let us know what the doctor says about the symptoms. Thanks.

VIEW AND REPLY